Cargando…

Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis

Patients with autoimmune disorders (AD) have altered cancer risks compared to the general population. Systemic lupus erythematosus and multiple sclerosis lead to a heightened risk for hematological malignancies and decreased risk for breast, ovarian, and prostate malignancies. Often patients with au...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Deborah K., Reynolds, Kaylia M., Poole, Brian D., Montierth, Matthew D., Todd, Vera M., Barnado, April, Davis, Mary F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822541/
https://www.ncbi.nlm.nih.gov/pubmed/33481783
http://dx.doi.org/10.1371/journal.pone.0243150
_version_ 1783639663343304704
author Johnson, Deborah K.
Reynolds, Kaylia M.
Poole, Brian D.
Montierth, Matthew D.
Todd, Vera M.
Barnado, April
Davis, Mary F.
author_facet Johnson, Deborah K.
Reynolds, Kaylia M.
Poole, Brian D.
Montierth, Matthew D.
Todd, Vera M.
Barnado, April
Davis, Mary F.
author_sort Johnson, Deborah K.
collection PubMed
description Patients with autoimmune disorders (AD) have altered cancer risks compared to the general population. Systemic lupus erythematosus and multiple sclerosis lead to a heightened risk for hematological malignancies and decreased risk for breast, ovarian, and prostate malignancies. Often patients with autoimmune disease have dysregulated antiviral immune responses, including against oncogenic viruses. To uncover the relationship between viral incidence and cancer risk in the context of autoimmune disease, we extracted electronic health records (EHR) from Vanderbilt University. ICD-9/10 codes and laboratory values were collected for hematological, lung, anal-vaginal, thyroid, hepatobiliary, bladder, prostate, and breast cancers; and viruses including Epstein Barr virus (EBV), Human papilloma virus (HPV), and Hepatitis A/B/C (Hep). Only viral infections that led to a physician visit or laboratory test were entered into the EMR; therefore, only clinically relevant cases were noted and considered positive in this study. The relationship between virus infection and cancer in an SLE cohort (SLE-cases n = 2,313, and SLE-controls n = 5,702) and an MS cohort (MS-case n = 7,277, MS-control n = 7,277) was examined by multilinear logistic regression. Viral infection was strongly associated with increased risk for cancer overall. SLE and MS patients were more susceptible to all viral infections. MS patients trended toward increased risk for cancers overall, while decreased risk for hormone-based cancers in SLE patients non-significantly reduced their risk for overall cancer. Both SLE and MS patients had increased clinically relevant EBV infection, which was associated with risk for hematological cancers. Preventing viral infections by vaccination may be especially helpful in controlling risk for cancer in SLE and MS patients.
format Online
Article
Text
id pubmed-7822541
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-78225412021-02-01 Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis Johnson, Deborah K. Reynolds, Kaylia M. Poole, Brian D. Montierth, Matthew D. Todd, Vera M. Barnado, April Davis, Mary F. PLoS One Research Article Patients with autoimmune disorders (AD) have altered cancer risks compared to the general population. Systemic lupus erythematosus and multiple sclerosis lead to a heightened risk for hematological malignancies and decreased risk for breast, ovarian, and prostate malignancies. Often patients with autoimmune disease have dysregulated antiviral immune responses, including against oncogenic viruses. To uncover the relationship between viral incidence and cancer risk in the context of autoimmune disease, we extracted electronic health records (EHR) from Vanderbilt University. ICD-9/10 codes and laboratory values were collected for hematological, lung, anal-vaginal, thyroid, hepatobiliary, bladder, prostate, and breast cancers; and viruses including Epstein Barr virus (EBV), Human papilloma virus (HPV), and Hepatitis A/B/C (Hep). Only viral infections that led to a physician visit or laboratory test were entered into the EMR; therefore, only clinically relevant cases were noted and considered positive in this study. The relationship between virus infection and cancer in an SLE cohort (SLE-cases n = 2,313, and SLE-controls n = 5,702) and an MS cohort (MS-case n = 7,277, MS-control n = 7,277) was examined by multilinear logistic regression. Viral infection was strongly associated with increased risk for cancer overall. SLE and MS patients were more susceptible to all viral infections. MS patients trended toward increased risk for cancers overall, while decreased risk for hormone-based cancers in SLE patients non-significantly reduced their risk for overall cancer. Both SLE and MS patients had increased clinically relevant EBV infection, which was associated with risk for hematological cancers. Preventing viral infections by vaccination may be especially helpful in controlling risk for cancer in SLE and MS patients. Public Library of Science 2021-01-22 /pmc/articles/PMC7822541/ /pubmed/33481783 http://dx.doi.org/10.1371/journal.pone.0243150 Text en © 2021 Johnson et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Johnson, Deborah K.
Reynolds, Kaylia M.
Poole, Brian D.
Montierth, Matthew D.
Todd, Vera M.
Barnado, April
Davis, Mary F.
Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis
title Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis
title_full Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis
title_fullStr Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis
title_full_unstemmed Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis
title_short Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis
title_sort contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822541/
https://www.ncbi.nlm.nih.gov/pubmed/33481783
http://dx.doi.org/10.1371/journal.pone.0243150
work_keys_str_mv AT johnsondeborahk contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis
AT reynoldskayliam contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis
AT poolebriand contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis
AT montierthmatthewd contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis
AT toddveram contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis
AT barnadoapril contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis
AT davismaryf contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis